21.07.2017 – 10:55

LifeWatch AG

EQS-Adhoc: LifeWatch AG: LifeWatch publishes results of Extraordinary General Meeting

EQS Group-Ad-hoc: LifeWatch AG / Key word(s): AGM/EGM
LifeWatch AG: LifeWatch publishes results of Extraordinary General Meeting

21-Jul-2017 / 10:50 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
--------------------------------------------------------------------------------
LifeWatch puplishes results of Extraordinary General Meeting

Zug/Switzerland, July 21, 2017 - LifeWatch AG (SIX Swiss Exchange: LIFE), a
leading developer and provider of medical solutions and remote diagnostic
monitoring services in the digital health market, publishes the results of
today's Extraordinary General Meeting. 6 shareholders attended the meeting in
Zurich and approximately 17,884,125 votes or 96.79% of the share capital were
represented. The outcome of the motions is summarized below:
Discharge for their activities in the fiscal year 2017 up to now was granted to
Dr. Robert Bider, Raymond W. Cohen, Thomas Rühle, Patrick Schildknecht, Markus
Breitenmoser, Dr. Stephan Rietiker, Dr. Christoph Heinzen, Stephanie Kravetz and
Andrew Moore.Elections to the Board of Directors for a term starting July 21,
2017 until the next Ordinary Annual General Meeting 2018. Following the
resignation of the previous Board of Directors and in accordance with the
Boards' recommendationJoseph Capper (President and Chief Executive Officer of
BioTelemetry, Inc.), Kirk Gorman (Chairman of the Board of BioTelemetry, Inc.)
and Dr. Stephan Rietiker (Chief Executive Officer of LifeWatch AG) were newly
elected as a member of the Board andKirk Gorman was elected as Chairman of the
Board of Directors.As recommended, Joseph Capper and Kirk Gorman were elected as
members of the Compensation Committee.The Extraordinary General Meeting newly
elected Ernst & Young AG, Zurich as statutory auditors for the remainder of the
financial year 2017.The Extraordinary General Meeting approved the proposed
amendments to the Articles of Incorporation on the introduction of Article 3bis
(conditional capital).
For further questions:
LifeWatch AG, Andrew Moore, CFO
c/o Communicators AG , Ralph Spillmann
Mobile: +41 79 514 64 84
E-Mail:  investor-relations@lifewatch.com

About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote diagnostic
patient monitoring services. LifeWatch's services provide physicians with
critical information to determine appropriate treatment and thereby improve
patient outcomes. LifeWatch AG has operative subsidiaries in the United States,
in Switzerland, Israel and Turkey, and is the parent company of LifeWatch
Services Inc., LifeWatch Technologies, Ltd. and LifeWatch Turkey Holding AG
(joint venture). LifeWatch Services, Inc. is a leading U.S.-based provider of
cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a
leading manufacturer of digital health products. LifeWatch Sağlık Hizmetlerine
A.S. is the operative Turkish subsidiary of LifeWatch Turkey Holding AG and
provider of mobile cardiac telemetry services in Turkey. For additional
information, please visitwww.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at
https://www.lifewatch.com/Investor-Relations/Alert-Service.html

This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position, the
business strategy, and plans and objectives for future operations, are
forward-looking statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar expressions are
intended to identify forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and projections about
future events and financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and long-term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND MUST
NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL
CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN
OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE
UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF
LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED
WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES
SECURITIES LAWS.

Additional features:


Document:http://n.eqs.com/c/fncls.ssp?u=PANCKHNCMT
Document title: 20170721_EGM decisions_EN_FINAL
--------------------------------------------------------------------------------
End of ad hoc announcement------------------------------------------------------

Language: English

Company:  LifeWatch AG

          Baarerstrasse 139

          6300 Zug

          Switzerland

Phone:    +41 41 728 67 78

Internet: www.lifewatch.com

ISIN:     CH0012815459

Valor:    811189

Listed:   Regulated Unofficial Market in Berlin, Stuttgart; Open Market in
Frankfurt; SIX Swiss Exchange



 

End of Announcement EQS Group News Service

--------------------------------------------------------------------------------

594565  21-Jul-2017 CET/CEST